The store will not work correctly when cookies are disabled.
N-(5-Chlorothiazol-2-yl)-4-phenoxybutanamide
ID: ALA4559333
PubChem CID: 145420084
Max Phase: Preclinical
Molecular Formula: C13H13ClN2O2S
Molecular Weight: 296.78
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCCOc1ccccc1)Nc1ncc(Cl)s1
Standard InChI: InChI=1S/C13H13ClN2O2S/c14-11-9-15-13(19-11)16-12(17)7-4-8-18-10-5-2-1-3-6-10/h1-3,5-6,9H,4,7-8H2,(H,15,16,17)
Standard InChI Key: USCYPPPGRYWDHZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
43.3634 -22.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3622 -23.4078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0703 -23.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7799 -23.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7771 -22.5847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0685 -22.1794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6556 -22.1799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.9480 -22.5886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2402 -22.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5325 -22.5890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8247 -22.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1171 -22.5893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.8245 -21.3633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.4093 -22.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3226 -21.3698 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.5232 -21.2001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1148 -21.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6618 -22.5150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1907 -20.4536 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
16 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.78 | Molecular Weight (Monoisotopic): 296.0386 | AlogP: 3.59 | #Rotatable Bonds: 6 |
Polar Surface Area: 51.22 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.97 | CX Basic pKa: ┄ | CX LogP: 3.37 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.83 | Np Likeness Score: -1.77 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |